Pennovation Works

@PennovationWork

We're an innovation hub, business incubator, and laboratory at that stimulates entrepreneurial activity. Powered by .

Philadelphia, PA
Vrijeme pridruživanja: rujan 2015.

Tweetovi

Blokirali ste korisnika/cu @PennovationWork

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PennovationWork

  1. Prikvačeni tweet
    9. pro 2019.

    Are you looking to know more about: 🔹 Updates on what our Members are working on 🔹Event recaps and notification of future events 🔹Available Spaces in Pennovation 🔹 So much more Sign up for our Pennovation Center Newsletter right here:

    Poništi
  2. 4. velj

    Have you heard KIZ and KOZ in conversations about tax credits? Want to know more? Join us for an informational lunch on February 6, 12:00 pm to 1:30 pm. Register below:

    Poništi
  3. proslijedio/la je Tweet

    Learn about the benefits of the Keystone Innovation Zone (KIZ) Program and the Keystone Opportunity Zone (KOZ) Program! Register for the Information Session hosted by :

    Poništi
  4. proslijedio/la je Tweet
    30. sij
    Poništi
  5. Poništi
  6. 30. sij

    We love seeing a Pennovation Center member at 7. () and a Pennovation Accelerator alum at 9. () on this year's ReaLIST Startups. Keep your eye on these companies in 2020!

    Poništi
  7. proslijedio/la je Tweet
    30. sij

    Thanks for the highlight! 🤩 honored to be listed among these inspiring companies out to change the world 🙌🏻 – mjesto: Pennovation Works

    Poništi
  8. proslijedio/la je Tweet
    30. sij
    Poništi
  9. proslijedio/la je Tweet
    30. sij
    Poništi
  10. 29. sij
    Poništi
  11. proslijedio/la je Tweet
    28. sij

    On March 11 at watch Philly's female thought leaders debate on the topics you care about, and cast your VOTE! Tickets available now!

    Poništi
  12. proslijedio/la je Tweet
    28. sij

    Do you have IP that would make a great company? Want to test it with customers? Join the Penn I-Corps program and turn that idea into a business and receive $2000 in grants. The spring course application period is open!

    Ovo je potencijalno osjetljiv multimedijski sadržaj. Saznajte više
    Poništi
  13. proslijedio/la je Tweet
    27. sij

    We hosted a panel discussion w/ on innovative approaches to addressing the challenges and barriers to research & drug development in . A big thank you to our panelists Jennifer Farmer, MS, CGC, Stephanie Fischer & Horizon’s Saba Sile, M.D.

    Poništi
  14. proslijedio/la je Tweet
    23. sij

    Read all about ⁦⁩ ⁦⁩ in ⁦⁩ “Design Shows Take On the Future. And It’s Not Pretty”!! Our B | reactor sits proudly ⁦⁩, a beautiful exhibition led by Maite Borjabad & Michelle Miller Fisher

    Poništi
  15. proslijedio/la je Tweet
    23. sij

    Even the NYT agrees that this exhibit is groundbreaking and provocative— via

    Poništi
  16. proslijedio/la je Tweet
    24. sij

    Join Carisma Therapeutic's Financial Controller, Elena Petrossian, for a lunch & learn about building out finance infrastructure at an early stage company. 🗓️: Feb. 11th @ 12pm 🎟️: 📍:

    Poništi
  17. proslijedio/la je Tweet
    23. sij

    From I-Corps to SXSW, JPM and funding updates, there is a lot of news and resources in our latest newsletter. Check it out! Don't get our e-news? Click the link and subscribe.

    Poništi
  18. proslijedio/la je Tweet
    22. sij

    What is the largest challenge in rare disease drug development? “From the clinical side, the population sizes are often too small. To establish a clinical endpoint to your trial can be quite an undertaking,” says Saba Sile

    Poništi
  19. 22. sij

    Not too late to register! ⏰ Tonight (1/22) at 5:30 pm! Learn about innovation in the Rare Disease space at our event with :

    Poništi
  20. proslijedio/la je Tweet
    21. sij
    Poništi
  21. proslijedio/la je Tweet
    21. sij

    Great to see so many and startups in the exhibit, it’s so thought provoking and worth the time!! 👏👏

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·